 Suet Nee Chen
Concepts (232)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiomyopathies | 11 | 2025 | 339 | 3.180 |
Why?
| | Lamin Type A | 7 | 2021 | 49 | 1.840 |
Why?
| | Cardiomyopathy, Dilated | 5 | 2021 | 358 | 1.710 |
Why?
| | Arrhythmias, Cardiac | 6 | 2025 | 360 | 1.540 |
Why?
| | Induced Pluripotent Stem Cells | 3 | 2024 | 277 | 1.240 |
Why?
| | Myocytes, Cardiac | 12 | 2024 | 547 | 1.150 |
Why?
| | Filamins | 4 | 2025 | 28 | 1.120 |
Why?
| | Cardiomyopathy, Hypertrophic | 10 | 2024 | 144 | 0.980 |
Why?
| | Arrhythmogenic Right Ventricular Dysplasia | 2 | 2017 | 60 | 0.890 |
Why?
| | Transposition of Great Vessels | 1 | 2022 | 41 | 0.730 |
Why?
| | Heart Septal Defects, Ventricular | 1 | 2022 | 45 | 0.720 |
Why?
| | Death, Sudden, Cardiac | 2 | 2025 | 246 | 0.710 |
Why?
| | Coronary Artery Disease | 4 | 2009 | 754 | 0.630 |
Why?
| | Mutation | 9 | 2024 | 4130 | 0.600 |
Why?
| | DNA Damage | 2 | 2021 | 440 | 0.600 |
Why?
| | Myocardium | 7 | 2024 | 947 | 0.520 |
Why?
| | Biology | 1 | 2018 | 89 | 0.500 |
Why?
| | Tumor Suppressor Protein p53 | 2 | 2021 | 536 | 0.460 |
Why?
| | Research Personnel | 1 | 2018 | 187 | 0.460 |
Why?
| | Muscle Proteins | 3 | 2012 | 244 | 0.450 |
Why?
| | Signal Transduction | 7 | 2024 | 5272 | 0.440 |
Why?
| | Mutation, Missense | 3 | 2021 | 337 | 0.410 |
Why?
| | Adipogenesis | 1 | 2013 | 56 | 0.390 |
Why?
| | Motivation | 1 | 2018 | 615 | 0.380 |
Why?
| | Gene Deletion | 2 | 2016 | 392 | 0.350 |
Why?
| | Cholesterol, HDL | 2 | 2009 | 202 | 0.330 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2012 | 199 | 0.320 |
Why?
| | Myofibroblasts | 2 | 2022 | 149 | 0.320 |
Why?
| | Sarcomeres | 2 | 2024 | 101 | 0.280 |
Why?
| | Genetic Association Studies | 1 | 2009 | 374 | 0.260 |
Why?
| | Haplotypes | 3 | 2007 | 509 | 0.250 |
Why?
| | Fibrosis | 7 | 2022 | 568 | 0.250 |
Why?
| | Humans | 29 | 2025 | 147293 | 0.230 |
Why?
| | Hyperlipoproteinemia Type II | 1 | 2005 | 32 | 0.220 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2009 | 2223 | 0.210 |
Why?
| | Hypertrophy, Left Ventricular | 2 | 2024 | 124 | 0.210 |
Why?
| | Serine Endopeptidases | 1 | 2005 | 130 | 0.210 |
Why?
| | Genetic Predisposition to Disease | 4 | 2021 | 2458 | 0.210 |
Why?
| | Genetic Markers | 1 | 2005 | 338 | 0.200 |
Why?
| | Animals | 17 | 2022 | 38410 | 0.200 |
Why?
| | Focal Adhesion Protein-Tyrosine Kinases | 1 | 2024 | 35 | 0.200 |
Why?
| | Hypolipidemic Agents | 1 | 2004 | 89 | 0.190 |
Why?
| | Cell Adhesion | 2 | 2021 | 451 | 0.190 |
Why?
| | Echocardiography | 3 | 2024 | 652 | 0.190 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2004 | 212 | 0.180 |
Why?
| | Receptor Protein-Tyrosine Kinases | 1 | 2024 | 231 | 0.180 |
Why?
| | Genotype | 4 | 2009 | 1875 | 0.180 |
Why?
| | Calcineurin | 2 | 2012 | 106 | 0.170 |
Why?
| | Microtechnology | 1 | 2021 | 8 | 0.170 |
Why?
| | Ion Channels | 2 | 2022 | 129 | 0.170 |
Why?
| | Haploinsufficiency | 1 | 2021 | 54 | 0.170 |
Why?
| | Heterozygote | 4 | 2025 | 317 | 0.170 |
Why?
| | Phenotype | 10 | 2025 | 3216 | 0.170 |
Why?
| | Carrier Proteins | 4 | 2024 | 731 | 0.170 |
Why?
| | Arteries | 1 | 2022 | 262 | 0.160 |
Why?
| | Mechanical Phenomena | 1 | 2021 | 80 | 0.160 |
Why?
| | Desmosomes | 2 | 2017 | 22 | 0.160 |
Why?
| | Regulatory Elements, Transcriptional | 1 | 2020 | 18 | 0.160 |
Why?
| | Mice | 10 | 2022 | 18491 | 0.160 |
Why?
| | Genetic Variation | 1 | 2005 | 995 | 0.150 |
Why?
| | DNA Repair | 1 | 2021 | 256 | 0.140 |
Why?
| | Cellular Senescence | 1 | 2021 | 229 | 0.140 |
Why?
| | E2F Transcription Factors | 1 | 2019 | 65 | 0.140 |
Why?
| | Lipids | 1 | 2004 | 723 | 0.140 |
Why?
| | RNA, Long Noncoding | 1 | 2020 | 173 | 0.130 |
Why?
| | Muscular Dystrophies | 1 | 2018 | 28 | 0.130 |
Why?
| | Myocardial Contraction | 2 | 2018 | 293 | 0.130 |
Why?
| | Genetic Testing | 1 | 2021 | 493 | 0.130 |
Why?
| | Gene Frequency | 3 | 2009 | 498 | 0.130 |
Why?
| | Work-Life Balance | 1 | 2018 | 23 | 0.130 |
Why?
| | Fatty Acids, Monounsaturated | 2 | 2009 | 55 | 0.130 |
Why?
| | Myosin Heavy Chains | 4 | 2024 | 183 | 0.120 |
Why?
| | Acetylcysteine | 2 | 2009 | 139 | 0.120 |
Why?
| | Desmoplakins | 1 | 2016 | 25 | 0.120 |
Why?
| | Linkage Disequilibrium | 2 | 2009 | 259 | 0.120 |
Why?
| | Heart Ventricles | 1 | 2021 | 767 | 0.120 |
Why?
| | Microscopy, Atomic Force | 3 | 2021 | 129 | 0.110 |
Why?
| | Transcription Factors | 1 | 2004 | 1747 | 0.110 |
Why?
| | Fibroblasts | 2 | 2022 | 1039 | 0.110 |
Why?
| | Apoptosis | 3 | 2021 | 2454 | 0.110 |
Why?
| | Membrane Proteins | 1 | 2021 | 1171 | 0.110 |
Why?
| | Adipocytes | 1 | 2016 | 223 | 0.100 |
Why?
| | Antioxidants | 2 | 2009 | 550 | 0.100 |
Why?
| | Mice, Knockout | 3 | 2021 | 3153 | 0.100 |
Why?
| | Mice, Transgenic | 4 | 2012 | 2197 | 0.100 |
Why?
| | Indoles | 2 | 2009 | 510 | 0.090 |
Why?
| | Risk Factors | 2 | 2022 | 11017 | 0.090 |
Why?
| | Tripartite Motif Proteins | 1 | 2012 | 39 | 0.090 |
Why?
| | Male | 12 | 2025 | 73950 | 0.090 |
Why?
| | Genomics | 1 | 2017 | 839 | 0.090 |
Why?
| | Triglycerides | 2 | 2005 | 529 | 0.090 |
Why?
| | Female | 12 | 2025 | 80076 | 0.090 |
Why?
| | Stem Cells | 1 | 2016 | 630 | 0.090 |
Why?
| | Cell Proliferation | 1 | 2019 | 2529 | 0.080 |
Why?
| | Biomedical Research | 1 | 2018 | 723 | 0.080 |
Why?
| | Cells, Cultured | 5 | 2021 | 4169 | 0.080 |
Why?
| | Gene Expression Regulation | 1 | 2020 | 2625 | 0.080 |
Why?
| | Amino Acid Sequence | 2 | 2012 | 2134 | 0.080 |
Why?
| | Models, Animal | 1 | 2012 | 394 | 0.080 |
Why?
| | Molecular Sequence Data | 2 | 2012 | 2886 | 0.080 |
Why?
| | Apolipoprotein A-I | 1 | 2009 | 39 | 0.070 |
Why?
| | Chromosomes, Human, Pair 9 | 1 | 2009 | 36 | 0.070 |
Why?
| | Heart Failure, Systolic | 1 | 2009 | 26 | 0.070 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2012 | 456 | 0.070 |
Why?
| | Genes, Dominant | 2 | 2007 | 100 | 0.070 |
Why?
| | Disease Models, Animal | 5 | 2021 | 4604 | 0.070 |
Why?
| | Middle Aged | 7 | 2025 | 36821 | 0.070 |
Why?
| | Cell Differentiation | 1 | 2016 | 2054 | 0.070 |
Why?
| | Cell Line | 1 | 2013 | 2832 | 0.070 |
Why?
| | Biomechanical Phenomena | 2 | 2024 | 873 | 0.070 |
Why?
| | DNA Mutational Analysis | 2 | 2007 | 414 | 0.060 |
Why?
| | Troponin T | 2 | 2024 | 63 | 0.060 |
Why?
| | Sulfhydryl Compounds | 1 | 2009 | 189 | 0.060 |
Why?
| | Phosphorylation | 3 | 2021 | 1721 | 0.060 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 3 | 2018 | 264 | 0.060 |
Why?
| | Rats | 4 | 2021 | 5613 | 0.060 |
Why?
| | Alleles | 1 | 2009 | 909 | 0.060 |
Why?
| | Cholesterol | 2 | 2005 | 410 | 0.060 |
Why?
| | Chromosome Mapping | 1 | 2007 | 512 | 0.060 |
Why?
| | Actins | 2 | 2024 | 428 | 0.060 |
Why?
| | Proprotein Convertases | 1 | 2005 | 16 | 0.060 |
Why?
| | Heptanoic Acids | 1 | 2005 | 67 | 0.060 |
Why?
| | Quantitative Trait Loci | 1 | 2007 | 389 | 0.050 |
Why?
| | Proprotein Convertase 9 | 1 | 2005 | 88 | 0.050 |
Why?
| | Pedigree | 2 | 2021 | 522 | 0.050 |
Why?
| | Fluorescent Antibody Technique | 2 | 2018 | 365 | 0.050 |
Why?
| | Electrocardiography, Ambulatory | 1 | 2025 | 64 | 0.050 |
Why?
| | Case-Control Studies | 1 | 2012 | 3660 | 0.050 |
Why?
| | Lipoprotein(a) | 1 | 2005 | 70 | 0.050 |
Why?
| | Chromosome Aberrations | 1 | 2005 | 168 | 0.050 |
Why?
| | Cardiac Myosins | 1 | 2024 | 37 | 0.050 |
Why?
| | Aged | 4 | 2009 | 26514 | 0.050 |
Why?
| | Aldosterone | 1 | 2004 | 42 | 0.050 |
Why?
| | Pyrroles | 1 | 2005 | 221 | 0.050 |
Why?
| | Pharmacogenetics | 1 | 2005 | 176 | 0.050 |
Why?
| | Multifactorial Inheritance | 1 | 2005 | 231 | 0.050 |
Why?
| | Transgenes | 1 | 2004 | 190 | 0.050 |
Why?
| | Anticholesteremic Agents | 1 | 2005 | 157 | 0.050 |
Why?
| | Adult | 5 | 2025 | 41405 | 0.050 |
Why?
| | Codon, Nonsense | 1 | 2023 | 45 | 0.050 |
Why?
| | Heart | 2 | 2022 | 628 | 0.050 |
Why?
| | Genome-Wide Association Study | 1 | 2009 | 1496 | 0.040 |
Why?
| | Smad3 Protein | 1 | 2021 | 42 | 0.040 |
Why?
| | Smad2 Protein | 1 | 2021 | 37 | 0.040 |
Why?
| | Mice, 129 Strain | 1 | 2021 | 85 | 0.040 |
Why?
| | Optical Tweezers | 1 | 2021 | 21 | 0.040 |
Why?
| | RNA, Messenger | 3 | 2020 | 2812 | 0.040 |
Why?
| | Electrocardiography | 1 | 2025 | 675 | 0.040 |
Why?
| | Animals, Genetically Modified | 3 | 2009 | 248 | 0.040 |
Why?
| | Nanotubes | 1 | 2021 | 46 | 0.040 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2005 | 448 | 0.040 |
Why?
| | Rabbits | 3 | 2009 | 654 | 0.040 |
Why?
| | Disease Progression | 1 | 2009 | 2890 | 0.040 |
Why?
| | Body Mass Index | 1 | 2009 | 2470 | 0.040 |
Why?
| | Actin Cytoskeleton | 1 | 2021 | 103 | 0.040 |
Why?
| | Severity of Illness Index | 1 | 2009 | 2973 | 0.040 |
Why?
| | NFATC Transcription Factors | 2 | 2012 | 95 | 0.040 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2021 | 177 | 0.040 |
Why?
| | Predictive Value of Tests | 1 | 2005 | 2133 | 0.040 |
Why?
| | Follow-Up Studies | 1 | 2009 | 5476 | 0.040 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 2 | 2012 | 174 | 0.030 |
Why?
| | Protein Conformation, alpha-Helical | 1 | 2018 | 18 | 0.030 |
Why?
| | Elastic Modulus | 1 | 2018 | 121 | 0.030 |
Why?
| | Structure-Activity Relationship | 1 | 2018 | 567 | 0.030 |
Why?
| | RNA | 1 | 2023 | 916 | 0.030 |
Why?
| | Prognosis | 1 | 2005 | 4383 | 0.030 |
Why?
| | Molecular Dynamics Simulation | 1 | 2018 | 268 | 0.030 |
Why?
| | Rats, Sprague-Dawley | 1 | 2021 | 2542 | 0.030 |
Why?
| | Algorithms | 1 | 2004 | 1868 | 0.030 |
Why?
| | Epigenesis, Genetic | 1 | 2020 | 708 | 0.030 |
Why?
| | Animals, Newborn | 1 | 2018 | 914 | 0.030 |
Why?
| | Risk Assessment | 1 | 2025 | 3784 | 0.030 |
Why?
| | DNA, Mitochondrial | 2 | 2006 | 212 | 0.030 |
Why?
| | Time Factors | 2 | 2021 | 7173 | 0.030 |
Why?
| | Wnt Signaling Pathway | 1 | 2016 | 212 | 0.030 |
Why?
| | Collagen | 2 | 2006 | 460 | 0.020 |
Why?
| | Family | 2 | 2007 | 690 | 0.020 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2012 | 153 | 0.020 |
Why?
| | Microscopy, Electron | 1 | 2012 | 417 | 0.020 |
Why?
| | Genes, Reporter | 1 | 2012 | 278 | 0.020 |
Why?
| | Microfilament Proteins | 1 | 2012 | 135 | 0.020 |
Why?
| | Protein Kinase Inhibitors | 1 | 2018 | 984 | 0.020 |
Why?
| | Calcium-Binding Proteins | 1 | 2012 | 222 | 0.020 |
Why?
| | Transfection | 1 | 2012 | 930 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2005 | 11947 | 0.020 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2012 | 459 | 0.020 |
Why?
| | Cell Size | 1 | 2009 | 94 | 0.020 |
Why?
| | Ventricular Fibrillation | 1 | 2009 | 64 | 0.020 |
Why?
| | Adolescent | 2 | 2024 | 22825 | 0.020 |
Why?
| | Chromosomes, Human | 1 | 2007 | 45 | 0.020 |
Why?
| | Lod Score | 1 | 2007 | 62 | 0.020 |
Why?
| | Young Adult | 1 | 2024 | 14437 | 0.020 |
Why?
| | Penetrance | 1 | 2007 | 30 | 0.020 |
Why?
| | Glutathione | 1 | 2009 | 370 | 0.020 |
Why?
| | MAP Kinase Signaling System | 1 | 2009 | 308 | 0.020 |
Why?
| | Genetic Linkage | 1 | 2007 | 273 | 0.020 |
Why?
| | Twins, Dizygotic | 1 | 2007 | 108 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2025 | 17560 | 0.010 |
Why?
| | Conserved Sequence | 1 | 2007 | 244 | 0.010 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2007 | 387 | 0.010 |
Why?
| | Matrix Metalloproteinase 1 | 1 | 2006 | 22 | 0.010 |
Why?
| | Malondialdehyde | 1 | 2006 | 31 | 0.010 |
Why?
| | Procollagen | 1 | 2006 | 24 | 0.010 |
Why?
| | Protein Processing, Post-Translational | 1 | 2009 | 480 | 0.010 |
Why?
| | Amino Acid Substitution | 1 | 2007 | 303 | 0.010 |
Why?
| | Lipid Peroxidation | 1 | 2006 | 169 | 0.010 |
Why?
| | Nonmuscle Myosin Type IIB | 1 | 2004 | 6 | 0.010 |
Why?
| | Cytochrome P-450 CYP11B2 | 1 | 2004 | 1 | 0.010 |
Why?
| | Myofibrils | 1 | 2004 | 53 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 980 | 0.010 |
Why?
| | Spironolactone | 1 | 2004 | 40 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2004 | 136 | 0.010 |
Why?
| | Glutamine | 1 | 2004 | 110 | 0.010 |
Why?
| | Hypertrophy | 1 | 2004 | 128 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2004 | 172 | 0.010 |
Why?
| | Base Sequence | 1 | 2007 | 2175 | 0.010 |
Why?
| | Cytoskeletal Proteins | 1 | 2004 | 158 | 0.010 |
Why?
| | Adenosine Triphosphatases | 1 | 2004 | 159 | 0.010 |
Why?
| | Cyclic AMP | 1 | 2004 | 208 | 0.010 |
Why?
| | Cadherins | 1 | 2004 | 204 | 0.010 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2004 | 383 | 0.010 |
Why?
| | Ventricular Function, Left | 1 | 2005 | 546 | 0.010 |
Why?
| | beta Catenin | 1 | 2004 | 254 | 0.010 |
Why?
| | Trans-Activators | 1 | 2004 | 398 | 0.010 |
Why?
| | Gene Expression | 1 | 2006 | 1481 | 0.010 |
Why?
| | DNA | 1 | 2006 | 1444 | 0.010 |
Why?
| | Oxidative Stress | 1 | 2005 | 1368 | 0.010 |
Why?
| | Calcium | 1 | 2004 | 1197 | 0.010 |
Why?
| | Gene Expression Profiling | 1 | 2004 | 1794 | 0.010 |
Why?
| | Aging | 1 | 2004 | 1992 | 0.010 |
Why?
| | Biomarkers | 1 | 2004 | 4351 | 0.010 |
Why?
| | Child | 1 | 2007 | 22979 | 0.000 |
Why?
|
|
Chen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|